Similar articles

• Severe pseudohypocalcemia after gadolinium-enhanced magnetic resonance angiography.

  Doorenbos CJ, Ozyilmaz A, van Wijnen M. Doorenbos CJ, et al. N Engl J Med. 2003 Aug 21;349(8):817-8. doi: 10.1056/NEJM200308213490822. N Engl J Med. 2003. PMID: 12930942 No abstract available.
• Spurious hypocalcemia after gadodiamide administration.

  Williams SF, Meek SE, Moraghan TJ. Williams SF, et al. Mayo Clin Proc. 2005 Dec;80(12):1655-7. doi: 10.4065/80.12.1655. Mayo Clin Proc. 2005. PMID: 16342660
• Gadolinium-based magnetic resonance imaging contrast agents in interventional radiology.

  Atar E. Atar E. Isr Med Assoc J. 2004 Jul;6(7):412-4. Isr Med Assoc J. 2004. PMID: 15274532 Review.
• Pseudohypocalcemia with MR imaging contrast agents: a cautionary tale.

  Choyke PL, Knopp MV. Choyke PL, et al. Radiology. 2003 Jun;227(3):627-8. doi: 10.1148/radiol.2273030348. Radiology. 2003. PMID: 12773668 No abstract available.
• [The magnetic resonance assessment of craniofacial fibrous dysplasia. The completion of the study with gadolinium administration and magnetic resonance angiography].

  Di Girolamo M, Scipioni A, Laghi A, Corsetti A, Ferone E, Pavone P, Passariello R. Di Girolamo M, et al. Radiol Med. 1996 Mar;91(3):313-6. Radiol Med. 1996. PMID: 8628950 Review. Italian. No abstract available.